BVF Partners
66
75M
56
2.20
5
0.15
31
- Areas of investment
Summary
The leading representative office of defined Corporate Investor is situated in the San Francisco. The venture was found in North America in United States.
The usual cause for the fund is to invest in rounds with 5 partakers. Despite the BVF Partners, startups are often financed by Purdue Pharma, Versant Ventures, MPM Capital. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, Wellington Management, Surveyor Capital.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Repare Therapeutics. For fund there is no match between the location of its establishment and the land of its numerous investments - Canada. Among the most successful fund investment fields, there are Health Care, Pharmaceutical.
The important activity for fund was in 2019. Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is generally included in 2-6 deals every year.
Investments analytics
Analytics
- Total investments
- 66
- Lead investments
- 5
- Exits
- 31
- Rounds per year
- 2.20
- Follow on index
- 0.15
- Investments by industry
- Biotechnology (63)
- Health Care (28)
- Therapeutics (26)
- Pharmaceutical (25)
- Life Science (21) Show 11 more
- Investments by region
-
- United States (51)
- Switzerland (5)
- Canada (5)
- Netherlands (1)
- Ireland (1) Show 3 more
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 82M
- Group Appearance index
- 0.92
- Avg. company exit year
- 3
- Avg. multiplicator
- 2.45
- Strategy success index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| MoonLake Immunotherapeutics | 11 May 2021 | Early Stage Venture | Switzerland, Zug, Zug | ||
| Shoreline Biosciences | 07 Feb 2021 | Biotechnology, Medical, Life Science | Early Stage Venture | 43M | United States, California, San Diego |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.